MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, HEPA has $3,069,952 in assets. $402,405 in debts.

Balance Sheets Overview

Current Ratio
1025.43%
Quick Ratio
1025.43%
Debt to Asset Ratio
13.11%
Unit: Dollar
Assets Breakdown
    • Cash
    • Prepaid expenses
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Convertible preferred stock-Seri...
    • Others

Balance Sheets
2025-12-31
Cash
1,828,062
Prepaid expenses
1,241,890
Total current assets
3,069,952
Total assets
3,069,952
Accounts payable
167,810
Accrued expenses
77,507
Notes payable, current
54,066
Total current liabilities
299,383
Derivative financial instrumentswarrants
103,022
Total liabilities
402,405
Convertible preferred stock-Series APreferred Stock
855,808
Convertible preferred stock-Series CPreferred Stock
839,320
Common stock0.0001 par value per share 120,000,000 shares authorized, 11,620,317 and 139,168 shares issued and outstanding at december 31, 2025 and 2024, respectively
1,162
Additional paid-in capital
247,060,568
Accumulated other comprehensive income (loss)
8,345
Accumulated deficit
-246,097,656
Total stockholders equity
2,667,547
Total liabilities and stockholders equity
3,069,952
Unit: Dollar.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash$1,828,062 Prepaid expenses$1,241,890 Total current assets$3,069,952 Total assets$3,069,952 Total liabilities andstockholders equity$3,069,952 Total stockholdersequity$2,667,547 Total liabilities$402,405 Accumulated deficit-$246,097,656 Additional paid-in capital$247,060,568 Total currentliabilities$299,383 Derivative financialinstrumentswarrants$103,022 Convertible preferredstock-Series APreferred...$855,808 Convertible preferredstock-Series CPreferred...$839,320 Accumulated othercomprehensive income (loss)$8,345 Common stock0.0001 parvalue per share...$1,162 Accounts payable$167,810 Accrued expenses$77,507 Notes payable,current$54,066

Hepion Pharmaceuticals, Inc. (HEPA)

Hepion Pharmaceuticals, Inc. (HEPA)